The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the management of portal hypertension: Update 2009

Hepatology

Volumn 51, Issue 1, 2010, Pages 306-

  Boyer, Thomas D ^a   Haskal, Ziv J ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ANTICOAGULANT THERAPY; BLEEDING; BUDD CHIARI SYNDROME; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; SPLENORENAL SHUNT; STENT; SURVIVAL RATE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; UNITED STATES; VARICOSIS;

BUDD-CHIARI SYNDROME; HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; STENTS;

EID: 73449132909     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23383     Document Type: Short Survey

References (7)

1. Boyer TD, Haskal Z. AASLD Practice Guidelines: The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. HEPATOLOGY 2005;41:386-400.
2. Bureau C, Garcia Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007;27:742-747.
3. Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A, et al.; for Vienna TIPS study group. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. HEPATOLOGY 2003;38:1043-1050.
4. Riggio O, Masini A, Efrati C, Nicolao F, Angeloni S, Salvatori FM, et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol 2005;42:674-679.
5. Henderson JM, Boyer TD, Kutner M, Galloway JR, Rikkers LF, Jeffers LJ, et al. Distal splenorenal shunt versus transjugular intrahepatic portal systemic shunt for variceal bleeding: A randomized trial. Gastroenterology 2006;130:1643-1651.
6. Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 2008;48:407-414.
7. Garcia-Pagan JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, et al. TIPS for Budd-Chiari syndrome: Long-term results and prognostics factors in 124 patients. Gastroenterology 2008;135:808-815.